Soleno Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.57 | -$0.57 | -$0.57 |
| Q2 2024 | 3 | -$0.61 | -$0.61 | -$0.61 |
| Q3 2024 | 5 | -$1.37 | -$0.80 | -$1.04 |
| Q1 2025 | 5 | -$0.78 | -$0.65 | -$0.71 |
| Q2 2025 | 4 | -$0.62 | -$0.62 | -$0.62 |
| Q3 2025 | 4 | -$0.50 | -$0.50 | -$0.50 |
| Q4 2025 | 4 | -$0.38 | -$0.38 | -$0.38 |
| Q1 2026 | 3 | -$0.66 | -$0.66 | -$0.66 |
| Q2 2026 | 3 | -$0.65 | -$0.65 | -$0.65 |
| Q3 2026 | 3 | -$0.62 | -$0.62 | -$0.62 |
| Q4 2026 | 3 | -$0.46 | -$0.46 | -$0.46 |
Soleno Therapeutics, Inc. Earnings Date And Information
Soleno Therapeutics, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-1.83 earnings per share for the quarter, missing analysts' consensus estimates of $-0.61 by $1.22. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Soleno Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-2.36 diluted earnings per share) and currently has a price-to-earnings ratio of -17.27. Soleno Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based on prior year's report dates.
Soleno Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | -$0.61 | -$1.83 | -1.22 | $0 | $0 |
| 08/07/2024 | Q2 2024 | -$0.63 | -$0.57 | 0.06 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.30 | -$0.59 | -0.29 | $0 | |
| 03/06/2024 | Q4 2023 | -$0.33 | $3.45 M | |||
| 11/07/2023 | Q3 2023 | -$0.95 | $0 | |||
| 08/08/2023 | Q2 2023 | -$0.70 | -$0.81 | -0.11 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.71 | -$0.88 | -0.17 | $0 | |
| 03/22/2023 | Q4 2022 | -$0.40 | $0 | |||
| 11/09/2022 | Q3 2022 | -$1.05 | -$0.67 | 0.38 | $0 | |
| 08/10/2022 | Q2 2022 | -$1.05 | -$0.84 | 0.21 | $0 | |
| 05/10/2022 | Q1 2022 | -$1.35 | -$0.73 | 0.62 | $0 | |
| 03/31/2022 | Q4 2021 | -$0.53 | $0 | |||
| 11/10/2021 | Q3 2021 | -$1.65 | -$1.53 | 0.12 | $0 | |
| 07/28/2021 | Q2 2021 | -$1.20 | -$2.07 | -0.87 | $0 | |
| 05/05/2021 | Q1 2021 | -$0.60 | -$1.69 | -1.09 | $0 | |
| 03/03/2021 | Q4 2020 | -$1.05 | -$0.54 | 0.51 | $0 | |
| 11/10/2020 | Q3 2020 | -$0.60 | -$1.61 | -1.01 | $0 | |
| 08/10/2020 | Q2 2020 | -$3.00 | -$2.40 | 0.6 | $0 | |
| 05/12/2020 | Q1 2020 | -$3.30 | -$1.97 | 1.33 | $0 | |
| 03/04/2020 | Q4 2019 | -$2.25 | -$5.33 | -3.08 | $0 |
Soleno Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Soleno Therapeutics, Inc.'s earnings date?
Soleno Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based off last year's report dates.
-
How can I listen to Soleno Therapeutics, Inc.'s earnings conference call?
The conference call for Soleno Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Soleno Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Soleno Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Soleno Therapeutics, Inc. generate each year?
Soleno Therapeutics, Inc. (:SLNO) has a recorded net income of $0. Soleno Therapeutics, Inc. has generated $-2.36 earnings per share over the last four quarters.
-
What is Soleno Therapeutics, Inc.'s price-to-earnings ratio?
Soleno Therapeutics, Inc. (:SLNO) has a price-to-earnings ratio of -17.27 and price/earnings-to-growth ratio is -0.44.
